Modified Oligonucleotides for Guiding RNA Cleavage Using Bacterial RNase P
- Authors: Novopashina D.S.1,2, Nazarov A.S.1,2, Vorobjeva M.A.1, Kuprushkin M.S.1, Davydova A.S.1, Lomzov A.A.1,2, Pyshnyi D.V.1,2, Altman S.3,4, Venyaminova A.G.1
-
Affiliations:
- Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences
- Novosibirsk State University
- Department of Molecular, Cellular and Developmental Biology, Yale University
- Division of Life Sciences, Arizona State University
- Issue: Vol 52, No 6 (2018)
- Pages: 905-912
- Section: Structural-Functional Analysis of Biopolymers and Their Complexes
- URL: https://journal-vniispk.ru/0026-8933/article/view/163752
- DOI: https://doi.org/10.1134/S0026893318060134
- ID: 163752
Cite item
Abstract
The ability of a series of novel modified external guide sequences (EGS oligonucleotides) to induce the hydrolysis of target RNA with bacterial ribonuclease P has been studied; the most efficient modification variants have been selected. We have found patterns of the oligonucleotide sugar-phosphate backbone modi-fications that enhance oligonucleotide stability in the biological environment and do not violate the ability to interact with the enzyme and induce the RNA hydrolysis. It has been shown that analogues of EGS oligonucleotides selectively modified at 2'-position (2'-O-methyl and 2'-fluoro) or at internucleotide phosphates (phosphoryl guanidines) can be used for the addressed cleavage of a model RNA target by bacterial RNase P. The ability of new phosphoryl guanidine analogues of oligodeoxyribonucleotides that are stable in biological media to induce the hydrolysis of target RNA with bacterial ribonuclease P has been shown for the first time. The modified EGS oligonucleotides with an optimal balance between functional activity and stability in biological media can be considered as potential antibacterial agents.
About the authors
D. S. Novopashina
Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences; Novosibirsk State University
Author for correspondence.
Email: danov@niboch.nsc.ru
Russian Federation, Novosibirsk, 630090; Novosibirsk, 630090
A. S. Nazarov
Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences; Novosibirsk State University
Email: danov@niboch.nsc.ru
Russian Federation, Novosibirsk, 630090; Novosibirsk, 630090
M. A. Vorobjeva
Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences
Email: danov@niboch.nsc.ru
Russian Federation, Novosibirsk, 630090
M. S. Kuprushkin
Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences
Email: danov@niboch.nsc.ru
Russian Federation, Novosibirsk, 630090
A. S. Davydova
Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences
Email: danov@niboch.nsc.ru
Russian Federation, Novosibirsk, 630090
A. A. Lomzov
Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences; Novosibirsk State University
Email: danov@niboch.nsc.ru
Russian Federation, Novosibirsk, 630090; Novosibirsk, 630090
D. V. Pyshnyi
Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences; Novosibirsk State University
Email: danov@niboch.nsc.ru
Russian Federation, Novosibirsk, 630090; Novosibirsk, 630090
S. Altman
Department of Molecular, Cellular and Developmental Biology, Yale University; Division of Life Sciences, Arizona State University
Email: danov@niboch.nsc.ru
United States, New Haven,, CT 06520; Tempe, AZ,
A. G. Venyaminova
Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences
Email: danov@niboch.nsc.ru
Russian Federation, Novosibirsk, 630090
Supplementary files
